Lundbeck provided lower-than-expected sales of essential items Vyepti and Rexulti in the 4th quarter, yet chief executive officer Charl van Zyl prefer to concentrate on the development of the medications for the complete year 2024.
发布者:BY MARIA OUTZE NIELSEN,转转请注明出处:https://robotalks.cn/lundbeck-ceo-is-very-satisfied-despite-lower-than-expected-sales-of-key-products/